BF738735

CAS No. 1436383-95-7

BF738735( BF 738735 | BF-738735 )

Catalog No. M11855 CAS No. 1436383-95-7

BF738735 is a novel, broad-spectrum inhibitor of enterovirus replication (EC50=4-71 nM) that specifically targets host cell factor PI4KIIIβ with IC50 of 5.7 nM.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 51 Get Quote
5MG 80 Get Quote
10MG 140 Get Quote
25MG 305 Get Quote
100MG Get Quote Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    BF738735
  • Note
    Research use only, not for human use.
  • Brief Description
    BF738735 is a novel, broad-spectrum inhibitor of enterovirus replication (EC50=4-71 nM) that specifically targets host cell factor PI4KIIIβ with IC50 of 5.7 nM.
  • Description
    BF738735 is a novel, broad-spectrum inhibitor of enterovirus replication (EC50=4-71 nM) that specifically targets host cell factor PI4KIIIβ with IC50 of 5.7 nM, 300-fold less potent for PI4KIIIα (IC50=1.7 uM); blocks viral RNA replication with IC50 of 77 nM in luciferase assays, strongly inhibits CVB3 and EV71 replicon replication at 1-5 uM; reduces the PI4P levels at the Golgi complex through a direct inhibition of PI4KIIIβ activity.
  • In Vitro
    BF738735 (Compound 1) strongly inhibits PI4KIIIβ activity in vitro, with an IC50 of 5.7 nM. BF738735 also impairs PI4KIIIα, but only at an ~300-fold-higher concentration (IC50 of 1.7 μM). In addition, the activity of BF738735 is analyzed on a set of 150 cellular kinases, including 13 lipid kinases at a concentration of 10 μM. For all kinases, the inhibition is less than 10%, indicating that BF738735 specifically inhibits PI4KIIIβ in vitro. BF738735 exhibits a broad spectrum of antiviral activity, as it inhibits all tested species of enteroviruses and rhinoviruses, with 50% effective concentrations ranging between 4 and 71 nM. BF738735 potently inhibits all viruses tested, with EC50s ranging between 4 and 71 nM. The cytotoxicity of BF738735, determined in parallel with the EC50 and using the same culture conditions for 3 to 4 days, is low, with CC50 values ranging from 11 to 65 μM, resulting in high selectivity indices. Low concentrations of BF738735 reduce the amount of luciferase to GuaHCl-treated levels, suggesting that the BF738735 blocks viral RNA replication. The EC50 of BF738735 in this assay is 77 nM, which is comparable to the inhibition observed in the multicycle assay for coxsackievirus serotype B3 (CVB3).
  • In Vivo
    BF738735 is well tolerated by specimens with good plasma levels of the antiviral in circulation and a complete inhibition with 25 mg/kg and some inhibition with 5 mg/kg dose is observed.
  • Synonyms
    BF 738735 | BF-738735
  • Pathway
    Microbiology/Virology
  • Target
    Enterovirus
  • Recptor
    Enterovirus
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    1436383-95-7
  • Formula Weight
    426.466
  • Molecular Formula
    C21H19FN4O3S
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO : 125 mg/mL 293.11 mM
  • SMILES
    OC1=CC=C(C=C1F)C2=C(C)N=C3C(NCC4=CC=CC(S(=O)(C)=O)=C4)=NC=CN32
  • Chemical Name
    2-fluoro-4-(2-methyl-8-((3-(methylsulfonyl)benzyl)amino)imidazo[1,2-a]pyrazin-3-yl)phenol

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. MacLeod AM, et al. ACS Med Chem Lett. 2013 May 8;4(7):585-9. 2. Melia CE, et al. Cell Rep. 2017 Oct 17;21(3):587-599. 3. van der Schaar HM, et al. Antimicrob Agents Chemother. 2013 Oct;57(10):4971-81. 4. Ulferts R, et al. Antimicrob Agents Chemother. 2016 Apr 22;60(5):2627-38.
molnova catalog
related products
  • MRL-1237

    MRL-1237 is a potent and selective inhibitor of the replication of Enteroviruses with EC50 of 1-10 uM, targets the nonstructural 2C protein.

  • Norwogonin

    Norwogonin isolated from Scutellaria baicalensis Georgi possesses antiviral activity against Enterovirus 71 (IC50: 31.83 μg/ml).

  • T-00127-HEV1

    T-00127-HEV1 is a broad-spectrum antienterovirus compound that selectively inhibits PI4KB activity with IC50 of 60 nM.